ArticleFrontiers in pharmacology2024

The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience.

Xueting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.